Elocta 3000 IU powder and solvent for injectable solution

Ask a doctor about a prescription for Elocta 3000 IU powder and solvent for injectable solution

0.0(1)

Maryna Kuznetsova

Cardiology16 years of experience

Dr Marina Kuznetsova is an internal medicine doctor and cardiologist with a PhD in medicine. She provides online consultations for adults with chronic and acute conditions, with a strong focus on cardiovascular health. Her approach is based on current clinical guidelines and evidence-based treatment strategies.

Areas of expertise:

dyslipidaemia and lipid metabolism disorders
prevention and management of atherosclerosis
blood pressure monitoring and antihypertensive therapy
arrhythmias: diagnosis, follow-up, and treatment adjustment
cardiovascular care and recovery support after Covid-19

Dr Kuznetsova helps patients manage cardiovascular risk factors, optimise long-term treatment, and gain clarity in complex health situations – all through accessible and structured online care.

Book a video appointment

Taisiya Minorskaya

Family medicine12 years of experience

Dr Taisiya Minorskaya is a family medicine doctor with an official licence to practise in Spain and over 12 years of clinical experience. She provides online consultations for adults and children, combining evidence-based medicine with a personalised, modern European approach.

She helps with:

Viral infections and cold symptoms (flu, sore throat, cough, runny nose)
Review and adjustment of antibiotics
Skin rashes and allergic reactions
Chronic condition flare-ups, high blood pressure, headaches, fatigue
Lab and test interpretation
Medication review and adaptation to European standards
Patient navigation: what tests are needed, which specialists to see, when an in-person visit is required

Dr Minorskaya also specialises in the diagnosis and management of gastrointestinal conditions, including bloating, abdominal pain, chronic nausea, IBS, and SIBO. She supports patients with unexplained physical symptoms that may be linked to somatisation or stress, helping them find relief and improve quality of life.

She offers care for people undergoing GLP-1 therapy (Ozempic, Mounjaro, and others) for weight management. Her support follows Spanish clinical guidelines, from treatment planning and side effect counselling to regular follow-ups and coordination with private or public healthcare providers.

Book a video appointment

Maryna Kuznetsova

Cardiology16 years of experience

Areas of expertise:

dyslipidaemia and lipid metabolism disorders
prevention and management of atherosclerosis
blood pressure monitoring and antihypertensive therapy
arrhythmias: diagnosis, follow-up, and treatment adjustment
cardiovascular care and recovery support after Covid-19

Dr Kuznetsova helps patients manage cardiovascular risk factors, optimise long-term treatment, and gain clarity in complex health situations – all through accessible and structured online care.

Book a video appointment

Taisiya Minorskaya

Family medicine12 years of experience

She helps with:

Viral infections and cold symptoms (flu, sore throat, cough, runny nose)
Review and adjustment of antibiotics
Skin rashes and allergic reactions
Chronic condition flare-ups, high blood pressure, headaches, fatigue
Lab and test interpretation
Medication review and adaptation to European standards
Patient navigation: what tests are needed, which specialists to see, when an in-person visit is required

Book a video appointment

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use Elocta 3000 IU powder and solvent for injectable solution

Introduction

Package Leaflet: Information for the User

ELOCTA 250 UI Powder and Solvent for Solution for Injection

ELOCTA 500 UI Powder and Solvent for Solution for Injection

ELOCTA 750 UI Powder and Solvent for Solution for Injection

ELOCTA 1000 UI Powder and Solvent for Solution for Injection

ELOCTA 1500 UI Powder and Solvent for Solution for Injection

ELOCTA 2000 UI Powder and Solvent for Solution for Injection

ELOCTA 3000 UI Powder and Solvent for Solution for Injection

ELOCTA 4000 UI Powder and Solvent for Solution for Injection

efmoroctocog alfa (recombinant coagulation factor VIII)

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Keep this leaflet, you may need to read it again.
If you have any further questions, ask your doctor, pharmacist, or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

What is ELOCTA and what is it used for
What you need to know before you use ELOCTA
How to use ELOCTA
Possible side effects
Storage of ELOCTA
Contents of the pack and other information

1. What is ELOCTA and what is it used for

ELOCTA contains the active substance efmoroctocog alfa, a recombinant coagulation factor VIII, Fc fusion protein. Factor VIII is a protein that is naturally produced by the body and is necessary for blood to clot and stop bleeding. ELOCTA is a medicine used to treat and prevent bleeding in patients of all ages with hemophilia A (a bleeding disorder caused by a lack of factor VIII).

ELOCTA is prepared using recombinant technology without the addition of any human or animal component in the manufacturing process.

How ELOCTA works

In patients with hemophilia A, factor VIII is missing or does not work properly. ELOCTA is used to replace the missing or deficient factor VIII. ELOCTA increases factor VIII levels in the blood and temporarily corrects the tendency to bleed.

2. What you need to know before you use ELOCTA

Do not use ELOCTA:

if you are allergic to efmoroctocog alfa or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start using ELOCTA.

There is a small chance that you may have an allergic reaction (anaphylactic reaction) to ELOCTA. Signs of allergic reactions include itching all over the body, hives, feeling of tightness in the chest, difficulty breathing, and low blood pressure. If any of these symptoms occur, stop the injection immediately and contact your doctor.

The formation of inhibitors (antibodies) is a known complication that can occur during treatment with all factor VIII medicines. These inhibitors, especially in large quantities, can prevent the treatment from working properly, so you and your child will be closely monitored for the development of such inhibitors. If your bleeding or your child's bleeding is not being controlled with ELOCTA, contact your doctor immediately.

Cardiovascular events

If you have heart disease or are at risk of heart disease, be careful when using factor VIII medicines and talk to your doctor.

Catheter-related complications

If you need a central venous access device (CVAD), consider the risk of CVAD-related complications, including local infections, bacteria in the blood, and thrombosis at the catheter insertion site.

Documentation

We strongly recommend that each time ELOCTA is administered, the product name and batch number are recorded.

Other medicines and ELOCTA

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Driving and using machines

No effects on the ability to drive or use machines have been observed.

ELOCTA contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per vial; this is essentially "sodium-free".

However, depending on your body weight and dose, you may receive more than one vial, which should be taken into account if you are on a low-sodium diet.

3. How to use ELOCTA

Treatment with ELOCTA will be started by a doctor who is experienced in the care of patients with hemophilia. Follow exactly the administration instructions for this medicine given by your doctor (see section Instructions for preparation and administration). If you are unsure, talk to your doctor, pharmacist, or nurse.

ELOCTA is given by injection into a vein. Your doctor will calculate your dose of ELOCTA (in International Units or "IU") based on your individual needs for factor VIII replacement treatment and whether it is used for prevention or treatment of bleeding. Talk to your doctor if you think you are not getting control of your bleeding with the dose you are receiving.

How often you need an injection will depend on how well ELOCTA is working for you. Your doctor will do the necessary laboratory tests to make sure you have adequate factor VIII levels in your blood.

Treatment of bleeding

The dose of ELOCTA is calculated based on your body weight and the desired factor VIII levels. The target factor VIII levels depend on the severity and location of the bleeding.

Prevention of bleeding

The usual dose of ELOCTA is 50 IU per kilogram of body weight, given every 3 to 5 days. Your doctor may adjust the dose within the range of 25 to 65 IU per kilogram of body weight. In some cases, especially in younger patients, shorter dosing intervals or higher doses may be needed.

Use in children and adolescents

ELOCTA can be used in children and adolescents of all ages. In children under 12 years of age, higher doses or more frequent injections may be needed.

If you use more ELOCTA than you should

Tell your doctor as soon as possible. Follow exactly the administration instructions for ELOCTA given by your doctor. If you are unsure, talk to your doctor, pharmacist, or nurse.

If you forget to use ELOCTA

Do not take a double dose to make up for forgotten doses. Take your dose as soon as you remember and then continue with your normal dosing schedule. If you are not sure what to do, talk to your doctor or pharmacist.

If you stop using ELOCTA

Do not stop using ELOCTA without talking to your doctor. If you stop using ELOCTA, you may no longer be protected against bleeding or an existing bleed may not stop.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If a severe and sudden allergic reaction (anaphylactic reaction) occurs, the injection should be stopped immediately. Contact your doctor immediately if you experience any of the following symptoms of allergic reactions: swelling of the face, rash, itching all over the body, hives, feeling of tightness in the chest, difficulty breathing, and low blood pressure.

In previously untreated children with factor VIII medicines (see section 2) inhibitors may occur very frequently (more than 1 in 10 patients); however, in patients who have received prior treatment with factor VIII (more than 150 days of treatment), the risk is infrequent (less than 1 in 100 patients). If this happens, the medicines may stop working properly and you may experience persistent bleeding. In this case, contact your doctor immediately.

The following side effects may occur with this medicine.

Uncommon side effects (may affect up to 1 in 100 people)

Headache, dizziness, taste disturbances, slow heart rate, high blood pressure, flushing, pain at the injection site, cough, lower abdominal pain, skin rash, papular rash, catheter-related thrombosis, joint swelling, muscle pain, back pain, joint pain, general malaise, chest pain, feeling of cold, feeling of heat, and low blood pressure.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of ELOCTA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after "EXP". The expiry date refers to the last day of the month shown.

Do not use this medicine if it has been stored at room temperature for more than 6 months.

Store in a refrigerator (2°C - 8°C).

Do not freeze.

Store in the original package to protect from light.

Alternatively, ELOCTA can be stored at room temperature (up to 30°C) for a single period not exceeding 6 months. Record the date when ELOCTA is removed from the refrigerator and stored at room temperature on the carton. After storage at room temperature, the medicine should not be returned to the refrigerator.

Once ELOCTA has been prepared, it should be used immediately. If it is not possible to use the prepared ELOCTA solution immediately, it should be used within 6 hours. Do not refrigerate the prepared solution. Protect the prepared solution from direct sunlight.

The prepared solution should be clear to slightly opalescent and colorless. Do not use this medicine if you notice it is cloudy or contains visible particles.

Dispose of any unused solution properly. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

ELOCTA Composition

The active ingredient is efmoroctocog alfa (recombinant coagulation factor VIII, Fc fusion protein). Each vial of ELOCTA nominally contains 250, 500, 750, 1,000, 1,500, 2,000, 3,000, or 4,000 IU of efmoroctocog alfa.

The other components are sucrose, sodium chloride, L-histidine, calcium chloride dihydrate, polysorbate 20, sodium hydroxide, hydrochloric acid, and water for injectable preparations. See section 2 if you are on a low-sodium diet.

Product Appearance and Container Contents

ELOCTA is presented as a powder and solvent for solution for injection. The powder is a white to off-white powder or cake. The solvent supplied for the preparation of the solution for injection is a clear and colorless solution. After preparation, the solution for injection is clear to slightly opalescent and colorless.

Each ELOCTA container contains 1 vial of powder, 3 mL of solvent in a prefilled syringe, 1 plunger rod, 1 vial adapter, 1 infusion set, 2 alcohol swabs, 2 band-aids, and 1 gauze.

Marketing Authorization Holder and Manufacturer

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm,

Sweden

Date of Last Revision of this Leaflet: 01/2021

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Turn the leaflet over to read the preparation and administration instructions.

Preparation and Administration Instructions

ELOCTA is administered by intravenous (IV) injection after dissolving the injectable powder with the solvent supplied in the prefilled syringe. The ELOCTA container contains:

Vial with powder, prefilled syringe, plunger rod, adapter, infusion set, alcohol swabs, band-aids, and gauze

ELOCTA must not be mixed with other injectable solutions or infusion solutions.

Wash your hands before opening the container.

Preparation:

Check the name and dose of the medication on the container to ensure it contains the correct medication. Check the expiration date on the ELOCTA carton. Do not use the medication if it is expired.

If ELOCTA has been stored in the refrigerator, let the ELOCTA vial (A) and the solvent syringe (B) reach room temperature before use. Do not use external heat.

Place the vial on a clean and flat surface. Remove the plastic closure cap from the ELOCTA vial.

Clean the top of the vial with one of the alcohol swabs (F) provided in the container and let it air dry. Do not touch the top of the vial or allow it to come into contact with anything once cleaned.

Remove the paper cover from the plastic vial adapter (D). Do not remove the adapter from its protective cap. Do not touch the inside of the vial adapter container.

Hold the vial adapter in its protective cap and place it directly over the top of the vial. Press firmly downward until the adapter is fully engaged with the top of the vial, with the adapter's spike penetrating the vial stopper.

Attach the plunger rod (C) to the solvent syringe by inserting the tip of the plunger rod into the syringe's plunger opening. Turn the plunger rod clockwise until it is securely seated on the syringe plunger.

Remove the tamper-evident plastic cap from the solvent syringe by bending it at the perforation until it breaks. Set the cap aside with the top facing down on a flat surface. Do not touch the inside of the cap or the syringe tip.

Remove the protective cap from the vial adapter by lifting it off and discarding it.

Connect the solvent syringe to the vial adapter by inserting the syringe tip into the adapter opening. Push firmly and turn the syringe clockwise until it is securely connected.

Slowly press the plunger rod downward to inject all of the solvent into the ELOCTA vial.

With the syringe still connected to the adapter and the plunger rod pressed downward, gently swirl the vial in a circular motion until the powder is dissolved.

Do not shake. Auto-injector device with connected vial rotating for proper use, curved arrows indicate movement

The final solution should be inspected visually before administration. The solution should be clear to slightly opalescent and colorless. Do not use the solution if it is cloudy or contains visible particles.

Ensuring the syringe plunger rod is still fully pressed downward, invert the vial. Slowly pull the plunger rod downward to transfer all of the solution into the syringe through the vial adapter.

Disconnect the syringe from the vial adapter by gently pulling the vial while turning it counterclockwise.

Note: If using more than one vial of ELOCTA per injection, each vial must be prepared separately according to the previous instructions (steps 1 to 13) and the solvent syringe must be removed, leaving the vial adapter in place. A single larger luer lock syringe may be used to withdraw the prepared contents from each of the vials.

Discard the vial and adapter.

Note: If the solution is not to be used immediately, the syringe cap should be carefully replaced over the syringe tip. Do not touch the syringe tip or the inside of the cap.

After preparation, ELOCTA can be stored at room temperature for a maximum of 6 hours before administration. After this time, the prepared ELOCTA solution must be discarded. Protect it from direct sunlight.

Administration (Intravenous Injection):

ELOCTA should be administered using the infusion set (E) provided in the container.

Open the infusion set container and remove the cap from the end of the tube. Connect the syringe with the prepared ELOCTA solution to the end of the infusion set tube by turning it clockwise.

Hand holding an infusion device with connected tubes and a transparent flow regulator

If necessary, apply a tourniquet and prepare the injection site by cleaning the skin well with the other alcohol swab provided in the container.

Hand applying a medicated patch to the skin of the arm showing the steps of adherence and pressure

Remove all air from the infusion set tube by slowly pressing the plunger rod downward until the liquid has reached the infusion set needle. Do not push the solution through the needle. Remove the transparent plastic protective cap from the needle.

Insert the infusion set needle into a vein as instructed by your doctor or nurse, and remove the tourniquet. If preferred, you can use one of the band-aids (G) provided in the container to secure the plastic wings of the needle in place at the injection site. The prepared product should be injected intravenously over several minutes. Your doctor may adjust the recommended injection rate to make it more comfortable for you.

Once the injection is complete and the needle is removed, the needle protector should be folded back and locked over the needle.

Hand holding a prefilled injection device with a black arrow indicating the direction of extraction of the protective shell

Discard the used needle, any unused solution, the syringe, and the empty vial in an appropriate medical waste container, as these materials may cause harm to others if not disposed of properly. Do not reuse the equipment.

Country of registration
Spain
Active substance
coagulation factor VIII
Prescription required
Yes
Manufacturer
Swedish Orphan Biovitrum Ab (Publ)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Alternatives to Elocta 3000 IU powder and solvent for injectable solution
ADVATE 1,000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1,000 IU
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required
ADVATE 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1500 IU
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required
ADVATE 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1000 IU - after reconstitution in 2 ml of water for injections, the dose is 500 IU/ml
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required

Alternatives to Elocta 3000 IU powder and solvent for injectable solution in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to Elocta 3000 IU powder and solvent for injectable solution in Poland

Pharmavate

Dosage form: Powder, 50 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Octapharma AB Octapharma Pharmazeutika Produktionsges.m.g.H. Octapharma S.A.S.

Prescription required

Pharmavate

Dosage form: Powder, 100 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Octapharma AB Octapharma Pharmazeutika Produktionsges.m.g.H. Octapharma S.A.S.

Prescription required

Beriate 2000

Dosage form: Powder, 2000 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 1000

Dosage form: Powder, 1000 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 500

Dosage form: Powder, 500 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 250

Dosage form: Powder, 250 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Alternative to Elocta 3000 IU powder and solvent for injectable solution in Ukraine

REFAKTO AF

Dosage form: lyophilizate, 500 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

REFAKTO AF

Dosage form: lyophilizate, 3000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

REFAKTO AF

Dosage form: lyophilizate, 250 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

REFAKTO AF

Dosage form: lyophilizate, 2000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

REFAKTO AF

Dosage form: lyophilizate, 1000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

OKTANAT

Dosage form: powder, 50 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Oktafarma AB (virobnictvo za povnim ciklom za viklucennam vtorinnoi upakovki)

Prescription required

Online doctors for Elocta 3000 IU powder and solvent for injectable solution

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Elocta 3000 IU powder and solvent for injectable solution – subject to medical assessment and local rules.

0.0(1)

Maryna Kuznetsova

Cardiology16 years of experience

Areas of expertise:

dyslipidaemia and lipid metabolism disorders
prevention and management of atherosclerosis
blood pressure monitoring and antihypertensive therapy
arrhythmias: diagnosis, follow-up, and treatment adjustment
cardiovascular care and recovery support after Covid-19

Dr Kuznetsova helps patients manage cardiovascular risk factors, optimise long-term treatment, and gain clarity in complex health situations – all through accessible and structured online care.

Book a video appointment

Taisiya Minorskaya

Family medicine12 years of experience

She helps with:

Viral infections and cold symptoms (flu, sore throat, cough, runny nose)
Review and adjustment of antibiotics
Skin rashes and allergic reactions
Chronic condition flare-ups, high blood pressure, headaches, fatigue
Lab and test interpretation
Medication review and adaptation to European standards
Patient navigation: what tests are needed, which specialists to see, when an in-person visit is required

Book a video appointment

Jonathan Marshall Ben Ami

Family medicine8 years of experience

Dr. Jonathan Marshall Ben Ami is a licensed family medicine doctor in Spain. He provides comprehensive care for adults and children, combining general medicine with emergency care expertise to address both acute and chronic health concerns.

Dr. Ben Ami offers expert diagnosis, treatment, and follow-up for:

Respiratory infections (cold, flu, bronchitis, pneumonia).
ENT conditions such as sinusitis, ear infections, and tonsillitis.
Digestive issues including gastritis, acid reflux, and irritable bowel syndrome (IBS).
Urinary tract infections and other common infections.
Management of chronic diseases: high blood pressure, diabetes, thyroid disorders.
Acute conditions requiring urgent medical attention.
Headaches, migraines, and minor injuries.
Wound care, health check-ups, and ongoing prescriptions.

With a patient-focused and evidence-based approach, Dr. Ben Ami supports individuals at all stages of life — offering clear medical guidance, timely interventions, and continuity of care.

Book a video appointment

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

12+ years of clinical experience in university hospitals in Germany and Spain.
International education: Ukraine – Germany – Spain.
Member of the German Society of Surgeons (BDC).
Certified in radiological diagnostics and robotic surgery.
Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment

Antonio Cayatte

General medicine43 years of experience

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic.

His clinical background includes:

assessment of sudden or unclear symptoms
ongoing care for chronic conditions
follow-up after hospital discharge
interpretation of test results
medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association.

Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Book a video appointment

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including:

Chronic pain lasting more than 3 months.
Migraines and recurring headaches.
Neck, back, lower back, and joint pain.
Post-traumatic pain following injury or surgery.
Nerve-related pain, fibromyalgia, and neuralgia.

In addition to pain management, Dr. Popov helps patients with:

Respiratory infections (colds, bronchitis, pneumonia).
High blood pressure and metabolic conditions such as diabetes.
Preventive care and routine health check-ups.

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Book a video appointment

Mar Tabeshadze

Endocrinology10 years of experience

Dr. Mar Tabeshadze is a licensed endocrinologist and general practitioner in Spain. She provides online consultations for adults, offering medical support for a wide range of endocrine conditions and related health concerns.

Diagnostic consultations for suspected endocrine disorders
Management of thyroid conditions, including in pregnant women
Early detection and treatment of type 1 and type 2 diabetes, with personalised therapy plans
Obesity treatment: identifying underlying causes of weight gain, combining medication and non-pharmacological strategies, and long-term support
Diagnosis and treatment of endocrine-related skin, hair, and nail issues
Ongoing care for patients with osteoporosis, pituitary, and adrenal gland disorders

Dr. Tabeshadze takes a patient-centred approach based on evidence-based medicine. Her goal is to help patients achieve hormonal balance, manage chronic conditions effectively, and improve overall well-being through targeted, personalised care.

Book a video appointment

Dmytro Horobets

Family medicine6 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment

Alexandra Alexandrova

General medicine8 years of experience

Dr Alexandra Alexandrova is a licensed general medicine doctor in Spain, specialising in trichology, nutrition, and aesthetic medicine. She offers online consultations for adults, combining a therapeutic approach with personalised care for hair, scalp, and overall health.

Areas of expertise:

Hair loss in women and men, postpartum hair loss, androgenetic and telogen effluvium.
Scalp conditions: seborrheic dermatitis, psoriasis, scalp irritation, dandruff.
Chronic conditions: hypertension, diabetes, metabolic disorders.
Online trichology consultation: customised treatment plans, nutritional support, hair growth stimulation.
Hair loss prevention: hormonal imbalance, stress factors, haircare strategies.
Routine health check-ups, prevention of cardiovascular and metabolic diseases.
Personalised nutritional advice to improve hair strength, skin health, and hormonal balance.
Aesthetic medicine: non-invasive strategies to enhance skin quality, tone, and metabolic wellness.

Dr Alexandrova follows an evidence-based and holistic approach: online consultations with a therapist and trichologist on Oladoctor provide professional support for hair, scalp, and overall health — all from the comfort of your home.

Book a video appointment